Skip to content

Clinical trials

Prostatic Neoplasms trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Country / region: Norway Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20031
20042
20051
20061
20073
20084
20093
20103
20114
20124
20133
20144
20153
20163
20176
20184
20192
20203
20215
20222
20233
20243
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Recruiting11
Active, not recruiting10
Unknown status7
Terminated4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Oslo University Hospital17
Norwegian University of Science and Technology5
AstraZeneca4
Bayer4
Ferring Pharmaceuticals3
Bristol-Myers Squibb2
European Organisation for Research and Treatment of Cancer - EORTC2
Scandinavian Prostate Cancer Group2
St. Olavs Hospital2
Sykehuset Innlandet HF2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms75
Breast Neoplasms5
Neoplasms5
Neoplasm Metastasis4
Bone Diseases1
Bone Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1
Disease1
Endometrial Neoplasms1

Trials

Showing 76 to 75 of 75. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.